---
title: "Positive Report for LeonaBio (LONA) from Mizuho Securities"
description: "Mizuho Securities analyst Graig Suvannavejh upgraded LeonaBio (LONA) to a Buy with a price target of $10.00. Suvannavejh, who focuses on the Healthcare sector, has an average return of 20.3% and a 50."
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/276278570.md"
published_at: "2026-02-18T21:55:33.000Z"
---

# Positive Report for LeonaBio (LONA) from Mizuho Securities

> Mizuho Securities analyst Graig Suvannavejh upgraded LeonaBio (LONA) to a Buy with a price target of $10.00. Suvannavejh, who focuses on the Healthcare sector, has an average return of 20.3% and a 50.00% success rate on recommended stocks. Additionally, TipRanks initiated coverage on LeonaBio with a Buy rating and a $5.00 price target.

Mizuho Securities analyst Graig Suvannavejh upgraded LeonaBio to a Buy today and set a price target of $10.00.

### President's Day Sale - 70% Off

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

Suvannavejh covers the Healthcare sector, focusing on stocks such as EyePoint Pharmaceuticals, Axsome Therapeutics, and Terns Pharmaceuticals. According to TipRanks, Suvannavejh has an average return of 20.3% and a 50.00% success rate on recommended stocks.

In a report released on February 4, TipRanks – Google also initiated coverage with a Buy rating on the stock with a $5.00 price target.

### Related Stocks

- [LONA.US - LeonaBio](https://longbridge.com/en/quote/LONA.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 在近期股价疲软后，Progyny (PGNY) 的估值受到关注 | Progyny (PGNY) 的股价经历了显著的下跌，最近下跌了 20.49%，至 17.69 美元，这使得投资者重新评估其估值。尽管过去一年总股东回报率为 21.48%，三年回报率为 51.15%，但该股票被认为被低估，公允价值估计为 3 | [Link](https://longbridge.com/en/news/277364504.md) |
| Wedbush 表示，休伦咨询有能力在核心垂直领域实现两位数的增长 | 休伦咨询（HURN）在核心领域有望实现两位数增长，原因是客户需求在市场波动中增加，Wedbush 表示。该公司第四季度的业绩在医疗保健和商业领域表现强劲，得益于新的人工智能和自动化服务。休伦的战略收购旨在增强行业专业知识并提高胜率。尽管该股 | [Link](https://longbridge.com/en/news/276916978.md) |
| Roth MKM 继续维持对 HEALWELL AI (AIDX) 的买入评级 | Roth MKM 分析师 Kyle Bauser 对 HEALWELL AI (AIDX) 维持了买入评级，目标价为 2.50 加元。Bauser 的平均回报为 -13.0%，成功率为 35.92%，专注于医疗保健行业。此外，Haywood | [Link](https://longbridge.com/en/news/277098766.md) |
| 桑德斯和穆林在外科医生总监的确认听证会上意见不合 | 在特朗普总统提名的外科医生候选人凯西·米恩斯的参议院确认听证会上，俄克拉荷马州共和党参议员马克韦恩·穆林批评了佛蒙特州独立参议员伯尼·桑德斯，指责《平价医疗法案》（ACA）导致医疗成本上升。双方的争论变得激烈，穆林指责桑德斯是问题的一部分， | [Link](https://longbridge.com/en/news/276919364.md) |
| Evolent Health 股票：深入探讨分析师观点（4 个评级） | 分析师对 Evolent Health（纽约证券交易所代码：EVH）的评级显示，在过去一个季度中，四位分析师的情绪从看涨到看跌不一。12 个月的平均目标价为 8.5 美元，比之前的目标价 11.62 美元下降了 26.85%。主要分析师已下 | [Link](https://longbridge.com/en/news/276890984.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.